129 related articles for article (PubMed ID: 17657603)
21. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
22. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
23. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy.
Han M; Jun SH; Song SH; Park HD; Park KU; Song J
Rapid Commun Mass Spectrom; 2014 Mar; 28(6):587-94. PubMed ID: 24519821
[TBL] [Abstract][Full Text] [Related]
24. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
25. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
[TBL] [Abstract][Full Text] [Related]
26. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
27. Biological variation of cardiac troponin T in patients with end-stage renal disease and in healthy individuals.
Corte Z; García C; Venta R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):53-60. PubMed ID: 25005457
[TBL] [Abstract][Full Text] [Related]
28. The impact of dialysis type on biomarkers for cardiovascular diseases.
Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
[TBL] [Abstract][Full Text] [Related]
29. Assessment of trace elements in sera of patients undergoing renal dialysis.
Hasanato RM
Saudi Med J; 2014 Apr; 35(4):365-70. PubMed ID: 24749133
[TBL] [Abstract][Full Text] [Related]
30. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
31. Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.
Madsen T; Christensen JH; Svensson M; Witt PM; Toft E; Schmidt EB
J Ren Nutr; 2011 Mar; 21(2):169-75. PubMed ID: 20833075
[TBL] [Abstract][Full Text] [Related]
32. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
[TBL] [Abstract][Full Text] [Related]
33. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
34. Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.
Kamijo Y; Wang L; Matsumoto A; Nakajima T; Hashimoto K; Higuchi M; Kyogashima M; Aoyama T; Hara A
Clin Exp Nephrol; 2012 Dec; 16(6):959-67. PubMed ID: 22552383
[TBL] [Abstract][Full Text] [Related]
35. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
38. Association of adiponectin with cardiovascular events in diabetic and non-diabetic hemodialysis patients.
Elokely A; Shoukry A; Ghonemy TA; Atia M; Amr G
Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):736-42. PubMed ID: 22805386
[TBL] [Abstract][Full Text] [Related]
39. [Determining factors of cardiac biomarkers in hemodialysed diabetic and non-diabetic patients].
Mácsai E; Széll J; Ladányi E; Treszl A; Vásárhelyi B; Madácsy L
Orv Hetil; 2007 Mar; 148(11):483-8. PubMed ID: 17350919
[TBL] [Abstract][Full Text] [Related]
40. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
